Search

Search bills, members, committees and pages...

GENETIX BIOTHERAPEUTICS, INC.

14 federal lobbying filings, 2023 to 2026.

GENETIX BIOTHERAPEUTICS, INC. is a client on 14 federal lobbying filings, 2023 to 2026, reporting $760K across them. Biotechnology and pharmaceutical company. Based in Massachusetts.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
ARNOLD & PORTER KAYE SCHOLER LLP14$760K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$120K
20254$240K
20244$240K
20234$160K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues14
MMMMedicare/Medicaid14
PHAPharmacy2

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 second_quarter$60KJul 17, 2026
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2026 first_quarter$60KApr 17, 2026
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 fourth_quarter$60KJan 14, 2026
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 third_quarter$60KOct 15, 2025
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 second_quarter$60KJul 17, 2025
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2025 first_quarter$60KApr 17, 2025
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 fourth_quarter$60KJan 17, 2025
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 third_quarter$60KOct 18, 2024
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 second_quarter$60KJul 18, 2024
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2024 first_quarter$60KApr 22, 2024
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 fourth_quarter$60KJan 18, 2024
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 third_quarter$60KOct 16, 2023
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 second_quarter$40KJul 19, 2023
GENETIX BIOTHERAPEUTICS, INC.ARNOLD & PORTER KAYE SCHOLER LLP2023 second_quarterJun 12, 2023